{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:35:17Z","timestamp":1787726117446,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA047347"],"award-info":[{"award-number":["R01 DA047347"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.josat.2023.209218","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:33:00Z","timestamp":1700346780000},"page":"209218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study"],"prefix":"10.1016","volume":"157","author":[{"given":"Andrew D.","family":"Tipping","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Nowels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary","family":"Samples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Robinson","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Heaps-Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209218_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107734","article-title":"Between- and within-person associations between opioid overdose risk and depression, suicidal ideation, pain severity, and pain interference","volume":"206","author":"Cleland","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209218_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109269","article-title":"Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients","volume":"232","author":"Crystal","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209218_bb0015","author":"Department of Health and Human Services Press Office"},{"key":"10.1016\/j.josat.2023.209218_bb0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209218_bb0025","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"10","author":"Fudala","year":"2003","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.josat.2023.209218_bb0030","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/pds.4772","article-title":"Identifying and classifying opioid-related overdoses: A validation study","volume":"28","author":"Green","year":"2019","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"5","key":"10.1016\/j.josat.2023.209218_bb0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/pds.4157","article-title":"Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records: Identifying Opioid Overdoses","volume":"26","author":"Green","year":"2017","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.josat.2023.209218_bb0040","article-title":"Drug overdose deaths in the United States, 1999\u20132020","volume":"428","author":"Hedegaard","year":"2021","journal-title":"NCHS Data Brief"},{"issue":"1","key":"10.1016\/j.josat.2023.209218_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209218_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107923","article-title":"The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose","volume":"209","author":"Karmali","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209218_bb0055","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","volume":"115","author":"Krawcyk","year":"2020","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209218_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"14","key":"10.1016\/j.josat.2023.209218_bb0065","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jama.2010.1427","article-title":"Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial","volume":"304","author":"Ling","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.josat.2023.209218_bb0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209218_bb0075","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2023.209218_bb0080","series-title":"September 28","author":"Missouri Department of Mental Health","year":"2018"},{"key":"10.1016\/j.josat.2023.209218_bb0085","series-title":"January 1","author":"Missouri Department of Mental Health","year":"2023"},{"key":"10.1016\/j.josat.2023.209218_bb0090","author":"Missouri overdose information"},{"key":"10.1016\/j.josat.2023.209218_bb0095","author":"Missouri Senate"},{"key":"10.1016\/j.josat.2023.209218_bb0100","author":"National Forensic Laboratory Information System"},{"key":"10.1016\/j.josat.2023.209218_bb0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2018.06.004","article-title":"Risks of fatal opioid overdose during the first year following nonfatal overdose","volume":"190","author":"Olfson","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209218_bb0110","series-title":"24","author":"Orgera","year":"2019"},{"issue":"9","key":"10.1016\/j.josat.2023.209218_bb0115","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/L17-0612","article-title":"Opioids and chest wall rigidity during mechanical ventilation","volume":"168","author":"Roan","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1016\/j.josat.2023.209218_bb0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MLR.0000000000000727","article-title":"Patterns of buprenorphine-naloxone treatment for opioid use disorder in a multistate population","volume":"55","author":"Saloner","year":"2017","journal-title":"Medical Care"},{"issue":"9","key":"10.1016\/j.josat.2023.209218_bb0125","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.josat.2023.209218_bb0130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/15563650701877374","article-title":"Fentanyl epidemic in Chicago, Illinois and surrounding Cook County","volume":"46","author":"Schumann","year":"2008","journal-title":"Clinical Toxicology"},{"issue":"6","key":"10.1016\/j.josat.2023.209218_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","volume":"19","author":"Sharma","year":"2017","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.josat.2023.209218_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108314","article-title":"Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance","volume":"216","author":"Shover","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209218_bb0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2017.05.051","article-title":"Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance","volume":"46","author":"Slavova","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.josat.2023.209218_bb0150","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/0033354920904087","article-title":"ICD-10-CM\u2013based definitions for emergency department opioid poisoning surveillance: Electronic health record case confirmation study","volume":"135","author":"Slavova","year":"2020","journal-title":"Public Health Reports"},{"key":"10.1016\/j.josat.2023.209218_bb0155","series-title":"May 10","author":"Substance Abuse and Mental Health Services Administration","year":"2023"},{"issue":"2","key":"10.1016\/j.josat.2023.209218_bb0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.119.258566","article-title":"Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis","volume":"371","author":"Torralva","year":"2019","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6","key":"10.1016\/j.josat.2023.209218_bb0165","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"issue":"Suppl. 1","key":"10.1016\/j.josat.2023.209218_bb0170","doi-asserted-by":"crossref","first-page":"i56","DOI":"10.1136\/injuryprev-2019-043521","article-title":"Defining indicators for drug overdose emergency department visits and hospitalisations in ICD-10-CM coded discharge data","volume":"27","author":"Vivolo-Kantor","year":"2021","journal-title":"Injury Prevention"},{"issue":"1","key":"10.1016\/j.josat.2023.209218_bb0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","article-title":"One-year mortality of patients after emergency department treatment for nonfatal opioid overdose","volume":"75","author":"Weiner","year":"2020","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.josat.2023.209218_bb0180","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.drugalcdep.2016.12.001","article-title":"The prescription opioid addiction treatment study: What have we learned","volume":"173","author":"Weiss","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209218_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsat.2019.06.015","article-title":"Implementation and evaluation of Missouri\u2019s Medication first treatment approach for opioid use disorder in publicly-funded substance use treatment programs","volume":"108","author":"Winograd","year":"2020","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:52:09Z","timestamp":1757433129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":37,"alternative-id":["S2949875923002692"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209218","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209218"}}